Assays & Kits

The RayPlex Atezolizumab (Tecentriq®) ADA kit is a cytometric bead assay to quantitatively measure Atezolizumab (Tecentriq®) antibodies by flow cytometry. The assay has been optimized for serum and plasma.

The RayPlex Tocilizumab (Actemra®) ADA kit is a cytometric bead assay to quantitatively measure Tocilizumab (Actemra®) antibodies by flow cytometry. The assay has been optimized for serum and plasma.

The RayPlex Tocilizumab (Actemra®) ADA kit is a cytometric bead assay to quantitatively measure Tocilizumab (Actemra®) antibodies by flow cytometry. The assay has been optimized for serum and plasma.

The RayPlex Golimumab (Simponi®) DA kit is a cytometric bead assay to quantitatively measure Golimumab (Simponi®) antibodies by flow cytometry. The assay has been optimized for serum and plasma.

The RayPlex Sarilumab (Kevzara®) DA kit is a cytometric bead assay to quantitatively measure Sarilumab (Kevzara®) antibodies by flow cytometry. The assay has been optimized for serum and plasma.

The RayPlex Trastuzumab DA kit is a cytometric bead assay to quantitatively measure Trastuzumab antibodies by flow cytometry. The assay has been optimized for serum and plasma.

The RayPlex Ustekinumab (Stelara®) DA kit is a cytometric bead assay to quantitatively measure Ustekinumab (Stelara®) antibodies by flow cytometry. The assay has been optimized for serum and plasma.

The RayPlex Ustekinumab (Stelara®) DA kit is a cytometric bead assay to quantitatively measure Ustekinumab (Stelara®) antibodies by flow cytometry. The assay has been optimized for serum and plasma.

The RayBio® Human TBNK Flow Cytometry Kit is designed to determine the percentages and absolute counts of mature human lymphocyte subsets in peripheral whole blood (WB). The subsets include T lymphocytes (CD3⁺), Helper T lymphocytes (CD3⁺CD4⁺), Cytotoxic T lymphocytes (CD3⁺CD8⁺), B lymphocytes (CD19⁺) and Natural killer (NK) lymphocytes (CD3⁻CD16&56⁺).